Shukra Pharmaceuticals Ltd
Shukra Pharma. | 524632
Share Price Chart - Shukra Pharmaceuticals Ltd
Stock Performance
Ratios
Consolidated data not available
Please try selecting a different data type
About Company
- Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016
- The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing
- The company provides varieties of products to the clientele
- Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others
- The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental
- Their manufacturing unit is located at Rakanpur in Gujarat
- The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc
- The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world
- In FY 2013-14, the Company got approval from Hon'ble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited with the erstwhile Relish Pharmaceuticals Limited and Re-organization of Share Capital of Relish Pharmaceuticals Limited through the Scheme of Arrangement vide Hon'ble High Court of Gujarat order dated 20 December, 2013
- The Company has achieved WHO-GMP certification, successfully securing a partnership with Meril Healthcare for robotic surgery projects in October 2025
Research Calls
Technical Indicators
Pivot Points
No Information Available
Volume Analysis data is not available at this time.
No Information Available
Growth Rate information is not available at this time.
All figures in ₹ Crores
No Information Available
No profit & lossdata available
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Shukra Pharmaceuticals Ltd?
The current share price of Shukra Pharmaceuticals Ltd (Shukra Pharma.) is ₹34.45. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Shukra Pharmaceuticals Ltd?
The Price-to-Earnings (P/E) ratio of Shukra Pharmaceuticals Ltd is 34.45. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Shukra Pharmaceuticals Ltd?
Shukra Pharmaceuticals Ltd has a 52-week high of ₹65.26 and a 52-week low of ₹17.06. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Shukra Pharmaceuticals Ltd?
Shukra Pharmaceuticals Ltd offers a dividend yield of 0.03%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Shukra Pharmaceuticals Ltd?
The Earnings Per Share (EPS) of Shukra Pharmaceuticals Ltd is ₹0.50. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Shukra Pharmaceuticals Ltd?
Shukra Pharmaceuticals Ltd has a Return on Equity (ROE) of 15.90%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
